SMTL ID : 9o63.1

Crystal structure of PLK4 and RP1664 complex

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.26 Å

Oligo State

monomer

Ligands

2 x SO4: SULFATE ION(Non-functional Binders)

SO4.1: 5 residues within 4Å: Chain A: E.91, T.146, N.148, N.150, K.152 6 PLIP interactions: 6 interactions with chain A Hydrogen bonds: A:E.91, A:T.146, A:T.146, A:N.148, A:N.150 Salt bridges: A:K.152 SO4.2: 3 residues within 4Å: Chain A: G.22, S.23, R.57 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:S.23 Salt bridges: A:R.57

1 x 01: 5-cyclopropyl-N~2~-[2,6-difluoro-4-(methanesulfonyl)phenyl]-N~2~-methyl-6-(1-methyl-1H-imidazol-4-yl)-N~4~-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine

01.3: 16 residues within 4Å: Chain A: L.19, G.20, V.27, R.29, A.40, E.91, M.92, C.93, H.94, N.95, G.96, E.97, R.100, L.144, A.154, D.155 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:L.19, A:V.27, A:L.144, A:L.144 Hydrogen bonds: A:C.93 Water bridges: A:E.97

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Vallee, F. et al., Discovery of RP-1664: A First-in-Class Orally Bioavailable, Selective PLK4 Inhibitor. J.Med.Chem. (2025)

Release Date

2025-05-28

Peptides

Serine/threonine-protein kinase PLK4: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Serine/threonine-protein kinase PLK4

Related Entries With Identical Sequence